Author

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Author Report for: Szalaj N

No contact information in database for Szalaj N




    Title: Preliminary studies of 1,5-benzoxazepine derivatives as potential histamine H(3) receptor antagonists
    Stefaniak-Napieralska M, Walczynski K, Iwan M, Korga-Plewko A, Szalaj N, Wieckowska A, Staszewski M
    Ref: Future Med Chem, :, 2024 : PubMed

            

    Title: Guanidines: Synthesis of Novel Histamine H(3)R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect
    Staszewski M, Iwan M, Werner T, Bajda M, Godyn J, Latacz G, Korga-Plewko A, Kubik J, Szalaj N and Walczynski K <3 more author(s)>
    Ref: Pharmaceuticals (Basel), 16:, 2023 : PubMed

            

    Title: Serotonin 5-HT(6) Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity-Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer's Disease
    Wieckowski K, Szalaj N, Gryzlo B, Wichur T, Goral I, Slugocka E, Sniecikowska J, Latacz G, Siwek A and Wieckowska A <3 more author(s)>
    Ref: Int J Mol Sci, 23:, 2022 : PubMed

            

    Title: Discovery of multifunctional anti-Alzheimers agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and gamma-aminobutyric acid transporters
    Pasieka A, Panek D, Jonczyk J, Godyn J, Szalaj N, Latacz G, Tabor J, Mezeiova E, Chantegreil F and Malawska B <10 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 218:113397, 2021 : PubMed

            

    Title: Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer's disease
    Szalaj N, Godyn J, Jonczyk J, Pasieka A, Panek D, Wichur T, Wieckowski K, Zareba P, Bajda M and Wieckowska A <3 more author(s)>
    Ref: J Enzyme Inhib Med Chem, 35:1944, 2020 : PubMed

            

    Title: Search for multifunctional agents against Alzheimer's disease among non-imidazole histamine H3 receptor ligands. In vitro and in vivo pharmacological evaluation and computational studies of piperazine derivatives
    Jonczyk J, Lodarski K, Staszewski M, Godyn J, Zareba P, Soukup O, Janockova J, Korabecny J, Salat K and Bajda M <6 more author(s)>
    Ref: Bioorg Chem, 90:103084, 2019 : PubMed

            

    Title: Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Abeta1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy
    Dgachi Y, Ismaili L, Knez D, Benchekroun M, Martin H, Szalaj N, Wehle S, Bautista-Aguilera OM, Luzet V and Marco-Contelles J <6 more author(s)>
    Ref: ChemMedChem, 11:1318, 2016 : PubMed

            

    Title: Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta
    Hebda M, Bajda M, Wieckowska A, Szalaj N, Pasieka A, Panek D, Godyn J, Wichur T, Knez D and Malawska B <1 more author(s)>
    Ref: Molecules, 21:, 2016 : PubMed

            

    Title: Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands
    Lazewska D, Jonczyk J, Bajda M, Szalaj N, Wieckowska A, Panek D, Moore C, Kuder K, Malawska B, Kiec-Kononowicz K
    Ref: Bioorganic & Medicinal Chemistry Lett, 26:4140, 2016 : PubMed

            

    Title: Multiple Ligands Targeting Cholinesterases and beta-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore
    Szalaj N, Bajda M, Dudek K, Brus B, Gobec S, Malawska B
    Ref: Arch Pharm (Weinheim), 348:556, 2015 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer